Skip to Content

Opportunities to Reduce the Rising Tide of Cardiovascular Events

Dec 15, 2023
12:00 pm EST
Presented by Family Heart Foundation
Register Now Registration takes place at a third-party website.

About This Webinar

Cardiovascular disease is still the leading cause of death in the US, with 2020 setting a record for deaths due to CVD at close to 1 million. After declining for many years, deaths due to cardiovascular disease have been increasing since 2010 and 80% of these deaths are preventable. LDL-cholesterol is a major modifiable cardiovascular risk factor which continues to be poorly controlled.

The Family Heart Foundation is a 501(c)(3) non-profit organization focused on research, education, and advocacy for people with the two most common inherited lipid disorders – familial hypercholesterolemia (FH) and elevated lipoprotein (a). From our proprietary Family Heart Foundation Database, we have examined the state of LDL-C control among 38 million Americans at high risk for cardiovascular disease (CVD). This session will explore insights from that analysis and propose potential solutions to prioritize LDL control and improve patient outcomes. Additionally, a panelist from Independent Health in Buffalo, New York, will be talking about strategies that Independent Health has employed to improve management of LDL-cholesterol in their plan members.

Finally, we'll discuss opportunities for improvement, including misaligned CMS quality measures, guideline simplification, plan benefit design, prior authorization, and patient out-of-pocket costs; and a recently released Family Foundation white paper entitled, "Prioritizing LDL-cholesterol Control" in conjunction with a Congressional Briefing on October 3 which contains recommendations for payers, practitioners, patients, and policy makers will be made available to all webinar attendees.

Attendees Will Learn About

  • Cholesterol treatment guidelines
  • Current state of LDL-cholesterol control in high-risk Americans
  • Strategies to improve LDL-C control
  • Impact of prior authorization on patient outcomes
  • Impact of current CMS quality measures


Erin Michos, MD

Director of Women's Cardiovascular Health Research and Associate Professor of Medicine

Johns Hopkins University

Dr. Erin Michos is an Associate Professor in the Division of Cardiology at the Johns Hopkins School of Medicine, with joint appointment in Epidemiology at the School of Public Health. She is the Director of Women’s Cardiovascular Health Research and the Associate Director of Preventive Cardiology at Johns Hopkins University. Dr. Michos is an internationally known expert in Preventive…

Learn more about Erin Michos, MD

Keith C Ferdinand, MD

Professor of Medicine and the Gerald S. Berenson Chair in Preventative Cardiology

Tulane University School of Medicine

Dr. Keith C. Ferdinand is a professor of medicine at the Tulane University School of Medicine. He has conducted numerous trials in hypertension lipids, cardiometabolic risk, and cardiovascular disease especially in racial and ethnic minorities, with over 250 peer-reviewed publications and lectures nationally and internationally. In addition to his clinical work, he has participated in numerous…

Learn more about Keith C Ferdinand, MD

Deirdre Wheat, MD, MPH

Medical Director, Quality, Disease and Case Management

Independent Health

Dr. Deirdre Wheat currently serves as medical director, quality, disease and case management at Independent Health providing clinical leadership across a wide range of programs. She received her medical degree from University College Galway in Ireland and a master of public health degree in epidemiology from University at Buffalo.

Learn more about Deirdre Wheat, MD, MPH

Hilliard “Hilly” Paige, Jr., BS

Chief Innovation Officer

Family Heart Foundation

Hilliard “Hilly” Paige, Jr. joined the Family Heart Foundation as the Chief Innovation Officer in October 2022. He has more than 30 years of leadership experience in the biopharmaceutical industry, including leading patient and professional advocacy functions, new product franchises, product development and commercialization teams, strategic planning and launch strategies for products in the…

Learn more about Hilliard “Hilly” Paige, Jr., BS